CYP3A5 and neoplasm: Together, this study suggests that GSCs activate STAT3 to upregulate CYP3A5 to fine-tune NAD+/NADH for the enhancement of mitochondrial functions and DNA damage repair, thereby fueling tumor stemness and conferring TMZ resistance, respectively.